Evidence-based policy: framework, results and analysis from the New Zealand biotechnology sector

ISSN： 0963-6048

Source： International Journal of Biotechnology, Vol.8, Iss.3-4, 2006-03, pp. : 206-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biotechnology in New Zealand: its origins, present state and future directions

By Rudzki Romuald E.J.

International Journal of Biotechnology, Vol. 8, Iss. 3-4, 2006-03 ,pp. : 285-303

Inderscience Publishers

Access to resources Recommend Favorite

Biotechnology business models work: Evidence from the pharmaceutical marketplace

By Glick J Leslie

Journal of Commercial Biotechnology, Vol. 14, Iss. 2, 2008-04 ,pp. : 106-117

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

University and small biotechnology firms linkage: the evidence from Brazil

By Galhardi Regina M.A.A.

International Journal of Biotechnology, Vol. 2, Iss. 4, 2003-07 ,pp. : 374-390

Inderscience Publishers

Access to resources Recommend Favorite

Biotechnology industry-physician interaction and OIG guidelines: Evidence from the stock market

By Jambulingam Thani Ghani WaQar Sharma Rajneesh

Journal of Commercial Biotechnology, Vol. 16, Iss. 4, 2010-10 ,pp. : 313-330

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

The use of performance measurements in the biotechnology sector

By Chong Yun Dai H. Gin

International Journal of Biotechnology, Vol. 12, Iss. 1-2, 2011-09 ,pp. : 104-121

Inderscience Publishers

Access to resources Recommend Favorite